Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

NCT03391193 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Multi-dose Quadrivalent Influenza Vaccine
BIOLOGICAL: Single-dose Quadrivalent Influenza Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company